Research test kit ACCEL-AMPLICON® 56G

oncology

The Accel-Amplicon 56G Oncology Panel v2 offers comprehensive and hotspot coverage of 56 clinically-relevant oncology-related genes. This panel utilizes a 263-amplicon design, covering over 16,000 COSMIC mutations, to generate targeted libraries compatible with Illumina sequencing platforms and now includes 104 exonic and gender Sample_ID amplicons spiked in at a low percentage (2-4% of reads) for tracking tumor-normal pairs and samples in longitudinal studies. The Accel-Amplicon 56G Oncology Panel v2 is compatible with short DNA fragments from both FFPE and cfDNA samples, and is well-suited for detection of clinically-relevant allele variants in DNA from circulating tumor cells (CTCs). This product is a complete kit that includes all components necessary for generating ready-to-sequence libraries, including primer pairs and indexed sequencing adapters. Features: Single-tube assay to interrogate 56G and Sample_ID targets Ready-to-sequence libraries in 2 hours Inputs as low as 10 ng Limit of detection as low as 1% Complete library generation in a single kit Includes sample tracking primers Benefits: On-target specificity and coverage uniformity > 95% Average amplicon size of 138 bp for compatibility with cfDNA and FFPE Easily track samples within and between studies Validate tumor/normal pairs and track samples throughout longitudinal studies Compliment WGS or exome sequencing for sample tracking Reduce sequencing cost with 384 indexing